Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
A Q&A with Nithin Stephen As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities...
Seeking an experienced fill/finish partner with available capacity today? You have come to the right place.
Are you an innovative company seeking a reliable CDMO partner to help move your drug substance program to its next phase of success? Look no further.
Event Overview: The Life Sciences industry relies on vast amounts of data to rapidly evaluate their novel therapies confidently at a global scale. To...
The Cytiva SA25 Aseptic Filling Workcell is a standardized system designed with flexibility built in. As an industry partner and collaborator,...
Download this on demand presentation detailing our drug substance manufacturing and drug product fill/finish capabilities. Simplify your GENE to IND...
The need for advanced technology platforms that offer a clear, end-to-end path to commercial manufacturing is driving biotech companies to outsource...